Description
Clindamycin Phosphate is a clear colorless solution for injection filled in a clear glass ampoule.
Formulation:
Each mL contains 182.93 mg clindamycin phosphate equivalent to 150 mg clindamycin.
Packaging/Availability:
USP Type I clear and colorless glass ampoule x 2mL (net content). Box of 1’s.
Indications & Dosage
Indications:
It is mainly bacteriostatic drug used in the treatment of serious anaerobic infections, notably due to Bacterodesfragilis. It is also used for Grand-positive infections due to pneumococci, staphylococci, streptococci such as liver abscess, actinomycosis, billary-tract infections, staphylococcal bone and joint infections, the carrier state of diphtheria, endophthalmis, gas gangrene, various gynaecological infections including bacterial vaginosis, endometritis and pelvic inflammatory disease, intra-abdominal infections including emphysema and pheumonia, septicaemia, and skin and soft-tissue infections involving heavy colonization with streptococci or anaerobes such as necrotizing fasciitis.
Dosage and Administration
Adults: Serious infections due to aerobic gram-positive cocci and the more susceptible anaerobes (NOT generally including Bacteroidesfragilis, Peptococcus species and Costridium perfringens): 600-1200mg/day in 2.3 or 4 equal doses either IM or Iv administration. More severe infections, particularly those due to proven or suspected Bacteroidesfragilis, Peptococcus species, or Clostridium species other than Clostridium perfringens:1200- 2700mg/day in 2,3 or 4 equal doses.
For more serious infections, these doses may have to be increased. In life-thretening situations due to either aerobes or anaerobes these doses may be increased. Doses of as much as 4800mg daily have been given intravenously to adults.
Neonates(Less than 1 month): 15 to 20mg/kg/day in 3 to 4 equal doses. The lower dosage may be adequate for small prematures.
Pediatric patients 1 month of age to 16 years: 20 to 40mg/kg/day in 3 or 4 equal doses either IM or IV administration. The higher doses would be used for more severe infections. As an alternative to dosing on a body weight basis, pediatric patients may be dosed on the basis of square meters body surface: 350mg/m2/day for serious infections and 450mg/m2/day for more severe infections.
Parenteral therapy may be changed to oral at the discretion of the physician. In cases of (beta)-
hemolytic streptococcal infections, treatment should be continued for at least 10 days.Or as
prescribed by the physician.
See insert for complete information
Distribution
Distributed by:
ASIANMEDS, INC.
8F RBMT Bldg., Corner C3 and 5th Ave.,
Grace Park, Caloocan City
Imported by:
EURO-CARE PRODUCTS PHILIPPINES
Tinio St., San Nicolas,
Gapan City, Nueva Ecija
Manufactured by:
FUREN PHARMACEUTICAL GROUP CO.,LTD.
Henan, China
Reviews
There are no reviews yet.